About Us
Company Profile
Executive Management
Board of Directors
Clinical Advisory Board
Our Pipeline
Our Science
For Patients
Investors & Media
Overview
News & Press Releases
Presentations
Publications
Events
SEC Filings
Stock Quote & Chart
Executive Management
Board of Directors
Board Committees
Corporate Governance
Clinical Advisory Board
Analyst Coverage
RSS Feeds
Contact Us
Contact Us
About Us
Company Profile
Executive Management
Board of Directors
Clinical Advisory Board
Our Pipeline
Our Science
For Patients
Investors & Media
Overview
News & Press Releases
Presentations
Publications
Events
SEC Filings
Stock Quote & Chart
Executive Management
Board of Directors
Board Committees
Corporate Governance
Clinical Advisory Board
Analyst Coverage
RSS Feeds
Contact Us
Contact Us
Home
>
Press Release
All
|
News
|
Press Release
|
Events
SAB Biotherapeutics Announces First Participant Dosed In Phase 1 Clinical Trial Of SAB-176 For Seasonal Influenza
July 30, 2020
SAB Biotherapeutics Closes Series B Funding
July 17, 2020
SAB Biotherapeutics President And CEO Eddie J. Sullivan, PhD, Featured On COVID-19 Panel At BIO Digital 2020
June 8, 2020
SAB Biotherapeutics Confirms Neutralizing Antibodies To SARS-CoV-2 And Begins Clinical Manufacturing Of Novel COVID-19 Therapeutic Candidate
May 28, 2020
SAB Biotherapeutics Advances Therapeutic For COVID-19 In Partnership With Department Of Defense And BARDA
April 16, 2020
CSL Behring And SAB Biotherapeutics Join Forces To Deliver New Potential COVID-19 Therapeutic
April 8, 2020
SAB Biotherapeutics Awarded $27M Contract to Develop Novel Rapid Response Capability for U.S. Department of Defense
March 31, 2020
SAB Biotherapeutics Delays Development At USD Discovery District
March 13, 2020
SAB Biotherapeutics Announces Research Collaboration With CSL Behring
January 7, 2020
SAB Biotherapeutics Raises $22M In Series A-2 Round
December 20, 2018
South Dakota Equity Partners Invests $1.05M In SAB Biotherapeutics
December 18, 2018
USD Discovery District Breaks Ground For First Building Project
November 20, 2018
Previous
Next